Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Beltsville, Maryland
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 386 filings
- On EDGAR
- CIK 1661059
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 31
News 8 of 64
Prospectuses and Registrations 8 of 24
- S-4 Registration statement for a merger or exchange Aug 18, 2026
- 424B5 Prospectus supplement for an offering Dec 19, 2025
- 424B1 Dec 11, 2025
- S-3 Shelf registration statement Nov 26, 2025
- 424B2 Prospectus supplement for an offering Jul 29, 2025
- S-3 Shelf registration statement Jul 18, 2025
- S-8 Registration statement for an employee plan Aug 4, 2023
- S-3 Shelf registration statement Aug 4, 2023
Proxies 8 of 18
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEFA14A Extra proxy material May 19, 2025
- DEFA14A Extra proxy material May 19, 2025
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- PRE 14A Preliminary proxy statement Apr 15, 2025
- DEFA14A Extra proxy material Apr 26, 2024
Ownership 8 of 205
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 12, 2026
- 4 Insider reported a trade Aug 12, 2026
- 4 Insider reported a trade Aug 3, 2026
- 4 Insider reported a trade Jul 29, 2026
Other 8 of 44
Everything here comes from NextCure, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.